The luxury gin brand has teamed up with the Italian shoe company on its first apparel collection, inspired by the brands' ...

Global Adrenogenital Syndrome Treatment MarketThe global Adrenogenital Syndrome Treatment Market is expected to achieve significant growth, reaching a market value of USD 12.81 billion in 2023. With a ...

Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) has settled another lawsuit alleging price fixing in the US. Teva ...

A decision in the 2013 U.S. Supreme Court case FTC v. Actavis found that while brand companies can be sued for engaging in reverse-payment, the payments themselves are not presumptively illegal.

During this time, the company was acquired by Actavis, then Allergan, and finally, Abbvie, which marked the end of Belding's time there. "I have been fortunate enough to have known Theresa for over 20 ...

Amneal and Shilpa have received the Food and Drug Administration’s permission for Boruzu, a new presentation of bortezomib for ready-to-use subcutaneous administration or intravenous ...

Attorneys general from 46 states and the District of Columbia expanded their antitrust case against the $75 billion generic drug industry to include 18 companies and at least 15 drugs. HARTFORD, Conn.

Jacob Doft co-founded long/short equity hedge fund Highline Capital in 1995 and is responsible for overseeing the investment activities of the firm. Highline Capital, whose unique culture is based ...

Actavis has sold an interest in its subsidiary in China to Zhejiang Chiral Medicine Chemicals Company. The Foshan, Guangdong-based interest has been divested just ten days after Actavis CEO said ...